These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 17629586)
21. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis]. Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320 [TBL] [Abstract][Full Text] [Related]
22. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation. Rainer F; Horvath A; Sandahl TD; Leber B; Schmerboeck B; Blesl A; Groselj-Strele A; Stauber RE; Fickert P; Stiegler P; Møller HJ; Grønbaek H; Stadlbauer V Aliment Pharmacol Ther; 2018 Mar; 47(5):657-664. PubMed ID: 29266346 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma. Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028 [TBL] [Abstract][Full Text] [Related]
24. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505 [TBL] [Abstract][Full Text] [Related]
25. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. Greisen SR; Moller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Jørgensen A; Hvid M; Deleuran B Clin Exp Rheumatol; 2011; 29(4):689-92. PubMed ID: 21813065 [TBL] [Abstract][Full Text] [Related]
26. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease. Kazankov K; Barrera F; Møller HJ; Rosso C; Bugianesi E; David E; Younes R; Esmaili S; Eslam M; McLeod D; Bibby BM; Vilstrup H; George J; Grønbaek H Liver Int; 2016 Oct; 36(10):1549-57. PubMed ID: 27102725 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel. Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354 [TBL] [Abstract][Full Text] [Related]
28. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. Hiraoka A; Horiike N; Akbar SM; Michitaka K; Matsuyama T; Onji M J Gastroenterol; 2005 Jan; 40(1):52-6. PubMed ID: 15692789 [TBL] [Abstract][Full Text] [Related]
29. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology. Lund Laursen T; Brøckner Siggard C; Kazankov K; Damgaard Sandahl T; Møller HJ; Ong A; Douglas MW; George J; Tarp B; Hagelskjaer Kristensen L; Lund Laursen A; Hiramatsu A; Nakahara T; Chayama K; Grønbaek H Scand J Gastroenterol; 2018 Aug; 53(8):986-993. PubMed ID: 29987961 [TBL] [Abstract][Full Text] [Related]
30. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease. Glavind E; Gotthardt DN; Pfeiffenberger J; Sandahl TD; Bashlekova T; Willemoe GL; Hasselby JP; Weiss KH; Møller HJ; Vilstrup H; Lee WM; Schilsky ML; Ott P; Grønbæk H Orphanet J Rare Dis; 2020 Jul; 15(1):173. PubMed ID: 32615997 [TBL] [Abstract][Full Text] [Related]
31. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782 [TBL] [Abstract][Full Text] [Related]
33. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure. Ptaszynska-Kopczynska K; Marcinkiewicz-Siemion M; Lisowska A; Waszkiewicz E; Witkowski M; Jasiewicz M; Miklasz P; Jakim P; Galar B; Musial WJ; Kaminski KA Cytokine; 2016 Apr; 80():7-12. PubMed ID: 26916171 [TBL] [Abstract][Full Text] [Related]
34. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study. Feng L; Zhou X; Su LX; Feng D; Jia YH; Xie LX PLoS One; 2012; 7(7):e38400. PubMed ID: 22911680 [TBL] [Abstract][Full Text] [Related]
35. Soluble Scavenger Receptor CD163 Is Associated with Severe Acute Kidney Injury in Patients with Hantaan Virus Infection. Zhang Y; Ma Y; Zhang C; Zhang Y; Zhuang R; Liu B; Yi J; Jin B Viral Immunol; 2015 May; 28(4):241-6. PubMed ID: 25789628 [TBL] [Abstract][Full Text] [Related]
36. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604 [TBL] [Abstract][Full Text] [Related]
38. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis. Suzuki Y; Shirai M; Asada K; Miwa S; Karayama M; Nakamura Y; Inui N; Shirai T; Hayakawa H; Baba S; Suda T Ann Am Thorac Soc; 2017 Jan; 14(1):57-64. PubMed ID: 27684274 [TBL] [Abstract][Full Text] [Related]
39. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Møller HJ; de Fost M; Aerts H; Hollak C; Moestrup SK Eur J Haematol; 2004 Feb; 72(2):135-9. PubMed ID: 14962251 [TBL] [Abstract][Full Text] [Related]
40. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses. Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]